EMOR (Healixa) Other Stockholders Equity: $0.00 Mil (As of . 20)


What is Healixa Other Stockholders Equity?

Healixa EMOR -9.87% Other Stockholders Equity is $0.00 Mil as of . 20.

Healixa's Other Stockholders Equity for the quarter that ended in . 20 was $0.00 Mil.

Healixa Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Healixa's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healixa Other Stockholders Equity Chart

Healixa Annual Data
Trend
Other Stockholders Equity

Healixa Quarterly Data
Other Stockholders Equity

Healixa Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.00 Mil mean?
Healixa (EMOR) has a Other Stockholders Equity of $0.00 Mil as of . 20. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Healixa and its competitors.
Is Healixa's Other Stockholders Equity too high?
Healixa's current Other Stockholders Equity is $0.00 Mil.
How does Healixa's Other Stockholders Equity compare to competitors?
Healixa's Other Stockholders Equity of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Healixa and its competitors. Healixa's current Other Stockholders Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healixa stock overvalued right now?
Healixa (EMOR) has a current Other Stockholders Equity of $0.00 Mil. The current Other Stockholders Equity is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Healixa (EMOR), the current Other Stockholders Equity is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Healixa Business Description

Address 273 Knickerbocker Avenue, Bohemia, New York, NY, USA, 11716
Healixa Inc is a technology company focused on building and acquiring disruptive technologies in the health-tech, clean water harvesting, and green-tech industries. Its activities consist mainly of research and development, intellectual property development, engineering validation, pilot deployment, and early-stage commercialization of its technology platforms. The company also focuses on clean water through its Eternal Spring Deposition Water Harvesting technology and on water harvesting and thermal cooling technologies.